EPRX
Eupraxia Pharmaceuticals Inc.
$6.92
+0.27 (+4.06%)
At close · Jul 8
Market Cap
$452.06M
Shares
65,326,947
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-04 | Virtual Investor Event at Digestive Disease Week 2026 | Event |
| 2026-04-21 | 2026 Bloom Burton & Co. Healthcare Investor Conference | Conference |
| 2026-04-14 | Raymond James Biotech Innovation Symposium | Event |
| 2025-10-01 | Webinar - Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs | Event |
| 2025-09-09 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-09-05 | Cantor Global Healthcare Conference | Conference |
| 2025-08-13 | Canaccord 45th Annual Growth Conference | Conference |
| 2025-05-14 | Tribe Public Webinar Presentation and Q&A Event titled, “Hard To Swallow: An Underdiagnosed Condition Rising To Surface (EOE) | Presentation |
| 2025-05-13 | Radius Research - Investments is hosting Eupraxia Pharmaceuticals with CEO James Helliwell for a Live Webinar and Q&A | Event |